Fostemsavir Tromethamine

N/A

Report date: 2026/03/30 17:02:26
First In Class

Base Information

Drug NameFostemsavir Tromethamine
Drug Alias NameTemsavir prodrug磷腾沙韦磷坦姆沙韦FostemsavirumHIV attachment inhibitor - ViiV Healthcare +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV envelope protein gp120 inhibitors
TargetsHIV envelope protein gp120
Therapy Area/IndicationsCardiovascular DiseasesHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/07/02
Country/TerritoryBelgiumCanadaUnited States +[26] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesPenta Global Foundation Pte LtdViiv Healthcare BvResearch Institute Of The Mcgill University Health Centre +[7] 
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsCardiovascular DiseasesHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ05A
Related LinksWikipediaDrugBankKEGG